Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

Nonhormonal drug for hot flash scores big in two phase III trials
02 Nov 2024
bởiJairia Dela Cruz
The novel neurokinin-1 and -3 receptor antagonist elinzanetant appears to reduce the frequency and severity of vasomotor symptoms (VMS), as well as improve sleep and menopause-related quality of life, as shown in two pivotal phase III trials.
02 Nov 2024

Dietary intake of n-3 PUFA prevents all-cause, CV deaths in diabetic people
02 Nov 2024
Individuals with prediabetes or diabetes may benefit from increased dietary intake of n-3 polyunsaturated fatty acids (PUFAs), particularly alpha-linolenic acid (ALA) and docosapentaenoic acid (DPA), which help lower the risk of all-cause and cardiovascular mortality, suggests a US study.
02 Nov 2024







